Broz, P., Pelegrín, P. & Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 43–157 (2020).
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).
Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116 (2016).
Wang, Q. et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature 579, 421–426 (2020).
Zhou, B. et al. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Res. 28, 1171–1185 (2018).
Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99–103 (2017).
Li, F. et al. mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy. Nat. Commun. 14, 4223 (2023).
Ploetz, E. et al. Metal–organic framework nanoparticles induce pyroptosis in cells controlled by the extracellular pH. Adv. Mater. 32, 1907267 (2020).
Ngai, W. S. C. et al. Bioorthogonally activatable base editing for on-demand pyroptosis. J. Am. Chem. Soc. 144, 5411–5417 (2022).
Li, M. et al. Photoredox catalysis may be a general mechanism in photodynamic therapy. Proc. Natl Acad. Sci. USA 119, e2210504 (2022).
Yu, L. et al. Photocatalytic superoxide radical generator that induces pyroptosis in cancer cells. J. Am. Chem. Soc. 144, 11326–11337 (2022).
Chen, B. et al. A pyroptosis nanotuner for cancer therapy. Nat. Nanotechnol. 17, 788–798 (2022).
Su, X. et al. Disruption of zinc homeostasis by a novel platinum(IV)-terthiophene complex for antitumor immunity. Angew. Chem. Int. Ed. 135, e202216917 (2022).
Zhang, W. et al. Bioorthogonal disruption of pyroptosis checkpoint for high-efficiency pyroptosis cancer therapy. J. Am. Chem. Soc. 145, 16658–16668 (2023).
Liu, X. et al. Apoptosis-amplified assembly of porphyrin nanofiber enhances photodynamic therapy of oral tumor. J. Am. Chem. Soc. 145, 7918–7930 (2023).
Li, M. et al. Photon-controlled pyroptosis activation (PhotoPyro): an emerging trigger for antitumor immune response. J. Am. Chem. Soc. 145, 6007–6023 (2023).
Chauhan, V. & Jain, R. Strategies for advancing cancer nanomedicine. Nat. Mater. 12, 958–962 (2013).
Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566–575 (2020).
Tu, Y. et al. Mimicking the cell: bio-inspired functions of supramolecular assemblies. Chem. Rev. 116, 2023–2078 (2016).
Cademartiri, L. & Bishop, K. Programmable self-assembly. Nat. Mater. 14, 2–9 (2015).
Wang, Y., Hu, Y. & Ye, D. Activatable multimodal probes for in vivo imaging and theranostics. Angew. Chem. Int. Ed. 61, e202209512 (2022).
Chagri, S., Ng, D. Y. W. & Weil, T. Designing bioresponsive nanomaterials for intracellular self-assembly. Nat. Rev. Chem. 6, 320–338 (2022).
Kim, J. et al. In situ self-assembly for cancer therapy and imaging. Nat. Rev. Mater. 8, 710–725 (2023).
Liang, G., Ren, H. & Rao, J. A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. 2, 54–60 (2010).
Zhang, Y. et al. Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides. Nat. Mater. 11, 817–826 (2012).
Jeena, M. T. et al. Mitochondria localization induced self-assembly of peptide amphiphiles for cellular dysfunction. Nat. Commun. 8, 26 (2017).
Yan, R. et al. Activatable NIR fluorescence/MRI bimodal probes for in vivo imaging by enzyme-mediated fluorogenic reaction and self-assembly. J. Am. Chem. Soc. 141, 10331–10341 (2019).
Feng, Z. et al. Enzyme-instructed peptide assemblies selectively inhibit bone tumors. Chem. 5, 2442–2449 (2019).
Li, J. et al. New power of self-assembling carbonic anhydrase inhibitor: short peptide–constructed nanofibers inspire hypoxic cancer therapy. Sci. Adv. 5, eaax0937 (2019).
An, H. et al. A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging. Nat. Commun. 10, 4861 (2019).
Gong, N. et al. Proton-driven transformable nanovaccine for cancer immunotherapy. Nat. Nanotechnol. 15, 1053–1064 (2020).
Pieszka, M. et al. Controlled supramolecular assembly inside living cells by sequential multistaged chemical reactions. J. Am. Chem. Soc. 142, 15780–15789 (2020).
Zhang, L. et al. Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo. Nat. Nanotechnol. 15, 145–153 (2020).
Borkowska, M. et al. Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells. Nat. Nanotechnol. 15, 331–341 (2020).
He, H., Liu, S., Wu, D. & Xu, B. Enzymatically formed peptide assemblies sequestrate proteins and relocate inhibitors to selectively kill cancer cells. Angew. Chem. Int. Ed. 59, 16445 (2020).
Song, Y. et al. Self-amplifying assembly of peptides in macrophages for enhanced inflammatory treatment. J. Am. Chem. Soc. 144, 6907–6917 (2022).
Wen, X. et al. Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics. Nat. Commun. 14, 800 (2023).
Guo, J. et al. Hierarchical assembly of intrinsically disordered short peptides. Chem 9, 2530–2546 (2023).
Ji, S. et al. Targeted enrichment of enzyme-instructed assemblies in cancer cell lysosomes turns immunologically cold tumors hot. Angew. Chem. Int. Ed. 60, 26994 (2021).
Li, W. et al. Molecular engineering of pH-responsive NIR oxazine assemblies for evoking tumor ferroptosis via triggering lysosomal dysfunction. J. Am. Chem. Soc. 145, 3736–3747 (2023).
Zhu, S. et al. Lysosomal quality control of cell fate: a novel therapeutic target for human diseases. Cell Death Dis. 11, 817 (2020).
Iulianna, T., Kuldeep, N. & Eric, F. The Achilles’ heel of cancer: targeting tumors via lysosome-induced immunogenic cell death. Cell Death Dis. 13, 509 (2022).
Wang, J. et al. Intracellular condensates of oligopeptide for targeting lysosome and addressing multiple drug resistance of cancer. Adv. Mater. 34, 2104704 (2022).
Wu, C. et al. Lysosome-targeted and fluorescence-turned ‘on’ cytotoxicity induced by alkaline phosphatase-triggered self-assembly. Adv. Healthc. Mater. 11, 2101346 (2022).
Jana, B. et al. Intra-lysosomal peptide assembly for the high selectivity index against cancer. J. Am. Chem. Soc. 145, 18414–18431 (2023).
Peng, J. et al. Weakly perturbative imaging of interfacial water with submolecular resolution by atomic force microscopy. Nat. Commun. 9, 122 (2018).
Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161–174 (2002).
Gamcsik, M. P., Kasibhatla, M. S., Teeter, S. D. & Colvin, O. M. Glutathione levels in human tumors. Biomarkers. 17, 671–691 (2012).
Xie, Z. et al. Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways. Cell Death Dis. 14, 255 (2023).
Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol. Immunol. 18, 1106–1121 (2021).
Martens, S. et al. MLKL in cancer: more than a necroptosis regulator. Cell Death Differ. 28, 1757–1772 (2021).
Yu, Y. et al. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 7, 193 (2021).
Bussi, C. et al. Lysosomal damage drives mitochondrial proteome remodelling and reprograms macrophage immunometabolism. Nat. Commun. 13, 7338 (2022).
Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015).
Curiel, T. et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9, 562–567 (2003).
